Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiago Torres

Showing results (131-140 of 274) with videos related to

Pageof 28
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 28, 2024
Interleukin-17 Inhibitors in the Treatment of Hidradenitis SuppurativaGonçalo Pinto Salgueiro, Orhan Yilmaz, Miguel Nogueira, et al.
The Journal of Dermatological Treatment|October 10, 2024
A systematic review of recent randomized controlled trials for palmoplantar pustulosisMiranda K Branyiczky, Shahnawaz Towheed, Tiago Torres, et al.
American Journal of Clinical Dermatology|June 22, 2026
Rethinking Head and Neck Atopic Dermatitis: Pathogenic Axes and Emerging Therapeutic DirectionsFrancisco José Navarro-Triviño, Ricardo Ruiz-Villaverde, Tiago Torres
Acta Medica Portuguesa|July 27, 2010
[Psoriasis in the era of biologics]Tiago Torres, Glória Cunha Velho, Madalena Sanches, et al.
European Journal of Dermatology : EJD|November 24, 2025
Successful use of risankizumab in a patient with severe psoriasis and active lung adenocarcinomaCésar Silva Ferreira, Marco Sousa, Margarida Contente, et al.
Dermatologic Therapy|October 13, 2022
Tapinarof for the treatment of psoriasisSofia Nogueira, Maria Alexandra Rodrigues, Ron Vender, et al.
The Journal of Dermatological Treatment|February 11, 2025
Oral roflumilast for psoriasis: a real-world 24-week prospective cohort studyAna Maria Lé, Orhan Yilmaz, Martim Luz, et al.
Dermatology and Therapy|November 20, 2024
A Narrative Review of the OX40-OX40L Pathway as a Potential Therapeutic Target in Atopic Dermatitis: Focus on Rocatinlimab and AmlitelimabAsaad Abdelhalim, Orhan Yilmaz, Mohamed Elshaikh Berair, et al.
International Journal of Molecular Sciences|October 25, 2016
Screening the Toxicity of Selected Personal Care Products Using Embryo Bioassays: 4-MBC, Propylparaben and TriclocarbanTiago Torres, Isabel Cunha, Rosário Martins, et al.
European Journal of Dermatology : EJD|November 28, 2013
Treatment of palmoplantar pustulosis with ustekinumab--the importance of interfering with the IL23/Th17 pathwayTeresa Pinto-Almeida, Tiago Torres, Madalena Sanches, et al.
Pageof 28

Showing results (131-140 of 274) with videos related to

Sort By:
Pageof 28
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 28, 2024
Interleukin-17 Inhibitors in the Treatment of Hidradenitis SuppurativaGonçalo Pinto Salgueiro, Orhan Yilmaz, Miguel Nogueira, et al.
The Journal of Dermatological Treatment|October 10, 2024
A systematic review of recent randomized controlled trials for palmoplantar pustulosisMiranda K Branyiczky, Shahnawaz Towheed, Tiago Torres, et al.
American Journal of Clinical Dermatology|June 22, 2026
Rethinking Head and Neck Atopic Dermatitis: Pathogenic Axes and Emerging Therapeutic DirectionsFrancisco José Navarro-Triviño, Ricardo Ruiz-Villaverde, Tiago Torres
Acta Medica Portuguesa|July 27, 2010
[Psoriasis in the era of biologics]Tiago Torres, Glória Cunha Velho, Madalena Sanches, et al.
European Journal of Dermatology : EJD|November 24, 2025
Successful use of risankizumab in a patient with severe psoriasis and active lung adenocarcinomaCésar Silva Ferreira, Marco Sousa, Margarida Contente, et al.
Dermatologic Therapy|October 13, 2022
Tapinarof for the treatment of psoriasisSofia Nogueira, Maria Alexandra Rodrigues, Ron Vender, et al.
The Journal of Dermatological Treatment|February 11, 2025
Oral roflumilast for psoriasis: a real-world 24-week prospective cohort studyAna Maria Lé, Orhan Yilmaz, Martim Luz, et al.
Dermatology and Therapy|November 20, 2024
A Narrative Review of the OX40-OX40L Pathway as a Potential Therapeutic Target in Atopic Dermatitis: Focus on Rocatinlimab and AmlitelimabAsaad Abdelhalim, Orhan Yilmaz, Mohamed Elshaikh Berair, et al.
International Journal of Molecular Sciences|October 25, 2016
Screening the Toxicity of Selected Personal Care Products Using Embryo Bioassays: 4-MBC, Propylparaben and TriclocarbanTiago Torres, Isabel Cunha, Rosário Martins, et al.
European Journal of Dermatology : EJD|November 28, 2013
Treatment of palmoplantar pustulosis with ustekinumab--the importance of interfering with the IL23/Th17 pathwayTeresa Pinto-Almeida, Tiago Torres, Madalena Sanches, et al.
Pageof 28